Drugs moving into the clinic: 23
The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators.
Archives for July 31, 2007
Sanofi Pasteur, Point Therapeutics, Amira Pharmaceuticals, Elusys Therapeutics and Chesapeake Pharmaceutical Packaging - People on the move
Sanofi Pasteur, Point Therapeutics, Amira Pharmaceuticals, Elusys Therapeutics and Chesapeake Pharmaceutical Packaging have all had people on the move in the world of pharmaceutical manufacturing.
Abraxis adds more manufacturing muscle
Abraxis BioScience has snapped up another manufacturing plant in its drive to expand production capabilities, this time announcing the purchase of Watson Pharmaceuticals' sterile injectables plant.
OSG strips contract manufacturing biz
Outsourcing Services Group (OSG) has announced it has sold its contract manufacturing subsidiary OSG Norwich Pharmaceuticals to a US private equity firm for an undisclosed amount.
GPC Biotech withdraws satraplatin NDA
GPC Biotech has withdrawn its hotly touted satraplatin New Drug Application (NDA) for accelerated approval following last week's less than glowing recommendation to hold off on its approval.